News Headlines Article

Pfizer taps Pleasanton’s SFJ Pharma to run late-stage lung cancer trial
San Francisco Business Times

SFJ Pharmaceuticals Inc., a Pleasanton-based company formed to run clinical trials for large drug companies, will conduct a Phase III trial of Pfizer Inc.’s experimental lung cancer drug dacomitinib. Financial terms of the deal were not disclosed, but SFJ said it will fund and supervise the trial across sites in Asia and Europe that will help the world’s largest drug maker (NYSE: PFE) submit dacomitinib for regulatory approval.

Commands